Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.28
    -0.11 (-4.60%)
    At close: Jun 13, 2025, 3:59 PM
    2.23
    -2.19%
    After-hours: Jun 13, 2025, 07:55 PM EDT

    NLS Pharmaceutics Statistics

    Share Statistics

    NLS Pharmaceutics has 3.6M shares outstanding. The number of shares has increased by -94.3% in one year.

    Shares Outstanding

    n/a
    		 3.6M

    Shares Change (YoY)

    n/a
    		 -94.3%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 22.34%

    Shares Floating

    n/a
    		 2.28M

    Failed to Deliver (FTD) Shares

    n/a
    		 8

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 157.05K, so 3.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 157.05K

    Short % of Shares Out

    n/a
    		 3.87%

    Short % of Float

    n/a
    		 4.32%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -73.77 and the forward PE ratio is 0.05. NLS Pharmaceutics's PEG ratio is 1.19.

    PE Ratio

    n/a
    		 -73.77

    Forward PE

    n/a
    		 0.05

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 -101.65

    P/FCF Ratio

    n/a
    		 -92.72

    PEG Ratio

    n/a
    		 1.19
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.23, with a Debt / Equity ratio of -0.18.

    Current Ratio

    n/a
    		 0.23

    Quick Ratio

    n/a
    		 0.23

    Debt / Equity

    n/a
    		 -0.18

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 -81.34

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,028,671.5

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -50% in the last 52 weeks. The beta is 0.04, so NLS Pharmaceutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.04

    52-Week Price Change

    n/a
    		 -50%

    50-Day Moving Average

    n/a
    		 1.76

    200-Day Moving Average

    n/a
    		 2.81

    Relative Strength Index (RSI)

    n/a
    		 56.4

    Average Volume (20 Days)

    n/a
    		 217,709

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -11.41K

    Operating Income

    n/a
    		 -11.81M

    Net Income

    n/a
    		 -12.17M

    EBITDA

    n/a
    		 -11.8M

    EBIT

    n/a
    		 -11.81M

    Earnings Per Share (EPS)

    n/a
    		 -0.32
    Full Income Statement

    Balance Sheet

    The company has 897.68K in cash and 1.63M in debt, giving a net cash position of -736.07K.

    Cash & Cash Equivalents

    n/a
    		 897.68K

    Total Debt

    n/a
    		 1.63M

    Net Cash

    n/a
    		 -736.07K

    Retained Earnings

    n/a
    		 -70.37M

    Total Assets

    n/a
    		 1.19M

    Working Capital

    n/a
    		 -6.53M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.68M and capital expenditures -4, giving a free cash flow of -9.68M.

    Operating Cash Flow

    n/a
    		 -9.68M

    Capital Expenditures

    n/a
    		 -4

    Free Cash Flow

    n/a
    		 -9.68M

    FCF Per Share

    n/a
    		 -0.25
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NLSP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NLSP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 27, 2024. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Sep 27, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 -148.28

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist